We are live on ! Find out more
SRCL

Stericycle Inc

Delisted

SRCL was delisted on the 1st of November, 2024.

506 hedge funds and large institutions have $5.34B invested in Stericycle Inc in 2018 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 156 increasing their positions, 188 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more funds holding in top 10

Funds holding in top 10: 56 (+1)

15% more first-time investments, than exits

New positions opened: 71 | Existing positions closed: 62

8% more capital invested

Capital invested by funds: $4.96B → $5.34B (+$387M)

1% more funds holding

Funds holding: 502506 (+4)

17% less repeat investments, than reductions

Existing positions increased: 156 | Existing positions reduced: 188

45% less call options, than puts

Call options by funds: $17.8M | Put options by funds: $32.2M

Holders
506
Holders Change
+4
Holders Change %
+0.8%
% of All Funds
11.58%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.14%
New
71
Increased
156
Reduced
188
Closed
62
Calls
$17.8M
Puts
$32.2M
Net Calls
-$14.4M
Net Calls Change
-$6.36M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$574M +$9.27M +148,935 +2%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$407M -$79.6M -1,279,854 -17%
BlackRock
3
BlackRock
New York
$351M +$8.32M +133,660 +3%
Invesco
4
Invesco
Georgia
$249M +$33.1M +532,675 +16%
Wells Fargo
5
Wells Fargo
California
$218M +$20.5M +329,741 +11%
State Street
6
State Street
Massachusetts
$215M +$1.19M +19,197 +0.6%
UBS AM
7
UBS AM
Illinois
$202M +$94.8M +1,523,235 +97%
Baillie Gifford & Co
8
Baillie Gifford & Co
United Kingdom
$167M -$640K -10,291 -0.4%
CCP
9
Clarkston Capital Partners
Michigan
$163M +$1.82M +29,225 +1%
FC
10
Fairpointe Capital
Illinois
$130M -$28M -450,625 -19%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$128M +$19.1M +307,201 +19%
CIP
12
Champlain Investment Partners
Vermont
$92.1M +$6.42M +103,270 +8%
Jennison Associates
13
Jennison Associates
New York
$85.3M -$1.85M -29,689 -2%
TSW
14
Thompson Siegel & Walmsley
Virginia
$83.1M -$40.8M -655,272 -34%
Goldman Sachs
15
Goldman Sachs
New York
$82.1M +$6.04M +97,143 +8%
Norges Bank
16
Norges Bank
Norway
$80.5M -$15.2M -244,015 -17%
Schroder Investment Management Group
17
Schroder Investment Management Group
United Kingdom
$75.9M -$3.72M -59,838 -5%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$74.6M +$7.03M +112,957 +11%
FWIA
19
Fort Washington Investment Advisors
Ohio
$63.1M +$849K +13,640 +1%
Northern Trust
20
Northern Trust
Illinois
$62M +$33.2K +534 +0.1%
AI
21
Ariel Investments
Illinois
$56.8M +$11.2M +180,266 +26%
MIP
22
Mondrian Investment Partners
United Kingdom
$52.2M -$106K -1,704 -0.2%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$50.2M +$3.22M +51,686 +7%
GTP
24
Global Thematic Partners
New York
$49M -$25.3M -405,888 -35%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$40.4M +$1.94M +31,103 +5%

SRCL Hedge Fund Activity: Q2 2018 in Review

506 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Stericycle Inc (SRCL) for Q2 2018, worth a combined $5.34B — up 7.8% from $4.96B a quarter earlier.

Buyers outnumbered sellers: 71 funds opened new SRCL positions and 62 closed out — a net gain of 9 holders — while 156 added to existing stakes and 188 trimmed.

The largest buyer was UBS AM, adding an estimated $94.8M. The largest seller was T. Rowe Price Associates, cutting an estimated $79.6M.

  • 506 institutional investors held Stericycle Inc (SRCL) as of Q2 2018, up from 502 in Q1 2018.
  • Funds reported $5.34B of Stericycle Inc stock for Q2 2018, up 7.8% quarter-over-quarter.
  • 71 funds opened new Stericycle Inc positions in Q2 2018 and 62 closed out, a net change of +9 holders.
  • The largest Stericycle Inc buyer in Q2 2018 was UBS AM, an estimated $94.8M added.
  • The largest Stericycle Inc seller in Q2 2018 was T. Rowe Price Associates, an estimated $79.6M sold.

Based on aggregated 13F filings for Q2 2018.